QELBREE 150 mg/1

QELBREE 150 mg is an extended-release capsule containing viloxazine hydrochloride, used for managing certain mental health conditions. This medication is designed to provide sustained relief and is manufactured by Supernus Pharmaceuticals, Inc.

QELBREE 150 mg is primarily used for the treatment of attention deficit hyperactivity disorder (ADHD) in adults. Viloxazine hydrochloride, the active ingredient, works to help manage symptoms associated with this condition. People often wonder, 'What is QELBREE used for?' and the answer lies in its ability to support focus and impulse control.

Common effects of QELBREE 150 mg may include changes in appetite, sleep disturbances, and mild gastrointestinal discomfort. Some users report feeling more alert and focused, while others may experience initial adjustments as their body adapts to the medication.

QELBREE 150 mg should be handled with care, especially if you have a history of heart conditions or high blood pressure. It is important to follow the guidance of a healthcare provider when starting or adjusting your dosage. Always store the medication in a cool, dry place away from children.

QELBREE 150 mg may interact with certain medications, including those that affect liver enzymes. It is advisable to discuss all current medications with your healthcare provider to avoid potential interactions. Alcohol and other central nervous system depressants should be used cautiously while taking QELBREE.